News
07-19-2011, 01:15 AM
Using a new in vivo screening system, Whitehead Institute researchers have identified a protein in the serine biosynthesis pathway that is essential in estrogen receptor (ER)-negative breast cancer a notoriously difficult disease to treat associated with low five-year survival rates...
More... (http://www.medicalnewstoday.com/releases/231291.php)
More... (http://www.medicalnewstoday.com/releases/231291.php)